PFWA
PYXS icon

Paces Ferry Wealth Advisors’s Pyxis Oncology PYXS Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Hold
11,440
– – 0.01% 133
2025
Q4 		$13.2K Buy
+11,440
New +$40.4K 0.01% 132

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paces Ferry Wealth Advisors's PYXS Position: Q1 2026 in Review

Paces Ferry Wealth Advisors held its Pyxis Oncology (PYXS) position steady in Q1 2026 at 11,440 shares worth $16.7K. The position accounts for 0.01% of the portfolio, ranked #133.

Paces Ferry Wealth Advisors first reported a position in PYXS in Q4 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Paces Ferry Wealth Advisors held 11,440 shares of Pyxis Oncology worth $16.7K as of Q1 2026.
  • Paces Ferry Wealth Advisors left its Pyxis Oncology share count unchanged in Q1 2026.
  • Pyxis Oncology made up 0.01% of Paces Ferry Wealth Advisors's portfolio in Q1 2026, its #133 holding.
  • Paces Ferry Wealth Advisors first reported a position in Pyxis Oncology in Q4 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.